articleJournal of Clinical InvestigationJan 2, 2008BRONZE OA

IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis

Massachusetts General Hospital · Shiga University of Medical Science · +2 more institutions

PubMed
Indexed incrossrefdoajpubmed

Abstract

Expression of IL-22 is induced in several human inflammatory conditions, including inflammatory bowel disease (IBD). Expression of the IL-22 receptor is restricted to innate immune cells; however, the role of IL-22 in colitis has not yet been defined. We developed what we believe to be a novel microinjection-based local gene-delivery system that is capable of targeting the inflamed intestine. Using this approach, we demonstrated a therapeutic potency for IL-22-mediated activation of the innate immune pathway in a mouse model of Th2-mediated colitis that induces disease with characteristics similar to that of IBD ulcerative colitis (UC). IL-22 gene delivery enhanced STAT3 activation specifically within colonic…

Citation impact

1,007
total citations
FWCI
36.89
Percentile
100%
References
62
Citations per year

Authors

9

Topics & keywords

Keywords
  • Ulcerative colitis
  • Colitis
  • Inflammatory bowel disease
  • Immunology
  • Inflammation
  • Mucus
  • Innate immune system
  • Immune system
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding